Prosecution Insights
Last updated: August 18, 2026

Examiner: CASH, KAILEY ELIZABETH

Tech Center 1600 • Art Units: 1637 1672 1683

This examiner grants 28% of resolved cases

Performance Statistics

27.8%
Allow Rate
-32.2% vs TC avg
71
Total Applications
+58.3%
Interview Lift
1366
Avg Prosecution Days
Based on 18 resolved cases, 2023–2026

Rejection Statute Breakdown

10.7%
§101 Eligibility
10.5%
§102 Novelty
35.0%
§103 Obviousness
30.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18557631 HIGH THROUGHPUT NUCLEIC ACID TESTING OF BIOLOGICAL SAMPLES Non-Final OA ABBOTT LABORATORIES
18163819 DIAGNOSTIC AND THERAPEUTIC METHODS FOR LYMPHOMA Non-Final OA Genentech, Inc.
18008989 COMPOSITIONS AND METHODS FOR DNA METHYLATION ANALYSIS Final Rejection President and Fellows of Harvard College
17768996 CLINICAL- AND INDUSTRIAL-SCALE INTACT-TISSUE SEQUENCING Final Rejection The Board of Trustees of the Leland Stanford Junior University
18157587 Methods Of Improving Health With Apolipoprotein E (APOE) Inhibitors Final Rejection Regeneron Pharmaceuticals, Inc.
18264741 A CONTINUOUS METRIC TO MEASURE ENDOTYPE AND CORTICOSTEROID INTERACTION IN SEPTIC SHOCK Final Rejection VANDERBILT UNIVERSITY
18324828 L-DNA ENCRYPTED TRACERS Final Rejection Vanderbilt University
18300814 METHODS AND COMPOSITIONS FOR PROBE DETECTION AND READOUT SIGNAL GENERATION Final Rejection 10x Genomics, Inc.
17801078 METHODS TO COMBINE FIRST AND SECOND STRAND cDNA SYNTHESIS FOR SPATIAL ANALYSIS Non-Final OA 10x Genomics, Inc.
17687376 SYSTEMS AND METHODS FOR BARCODING CELLS AND CELL BEADS Non-Final OA 10x Genomics, Inc.
17634908 CONTROLLING THE DNA HYBRIDIZATION CHAIN REACTION Final Rejection NORTHWESTERN UNIVERSITY
18388088 THERAPEUTIC STRATEGIES TO TARGET TUMORS WITH ALTERATIONS IN LKB1 PATHWAY Non-Final OA New York University
18000222 SINGLE CELL COMBINATORIAL INDEXING FROM AMPLIFIED NUCLEIC ACIDS Final Rejection THE GENERAL HOSPITAL CORPORATION
17864930 DECENTRALIZED WORKFLOWS FOR SINGLE CELL ANALYSIS Non-Final OA ILLUMINA, INC.
18203189 Quantum Dot-Peptide PNA-DNA Complexes as a Platform Reporter System for Multiplexed Detection in Cell-Free Transcription Translation-Based Biosensors Non-Final OA The Government of the United States of America, as represented by the Secretary of the Navy
18577860 A METHOD FOR DETECTION OF TARGET NUCLEIC ACID USING ISOTHERMAL AMPLIFICATION Non-Final OA Agency for Science, Technology and Research
17617218 INHIBITATION OF ACID LIPASE FOR CANCER THERAPY Non-Final OA Heinrich-Heine-Universität Düsseldorf

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month